Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
CALL
Franco-Nevada
FNV
$46B
| $24.1M | 0.01% |
+166,000
| New | +$24M |
|
802
Allegion
ALLE
$14.4B
| $24M | 0.01% |
172,176
+58,539
| +52% | +$8M |
|
803
Factset
FDS
$10.2B
| $23.9M | 0.01% |
71,170
+28,602
| +67% | +$9.36M |
|
|
CMA
804
DELISTED
Comerica
CMA
| $23.8M | 0.01% |
334,044
+49,763
| +18% | +$3.69M |
|
805
C.H. Robinson
CHRW
$17.5B
| $23.8M | 0.01% |
254,170
-51,943
| -17% | -$5.06M |
|
806
PUT
Gilead Sciences
GILD
$165B
| $23.8M | 0.01% |
345,000
+315,000
| +1,050% | +$21M |
|
807
Entegris
ENTG
$23.2B
| $23.7M | 0.01% |
192,884
-23,671
| -11% | -$2.72M |
|
808
Cedar Fair
FUN
$1.67B
| $23.6M | 0.01% |
526,627
+227,469
| +76% | +$10.8M |
|
809
PUT
ConocoPhillips
COP
$141B
| $23.6M | 0.01% |
386,730
+235,000
| +155% | +$13.1M |
|
810
CALL
Labcorp
LH
$25.9B
| $23.4M | 0.01% |
+98,940
| New | +$22.5M |
|
811
Zions Bancorporation
ZION
$10.3B
| $23.4M | 0.01% |
443,329
+43,906
| +11% | +$2.46M |
|
812
RH
RH
$3.71B
| $23.4M | 0.01% |
34,427
-1,102
| -3% | -$716K |
|
|
MRO
813
DELISTED
Marathon Oil Corporation
MRO
| $23.4M | 0.01% |
1,715,069
-980,540
| -36% | -$11.8M |
|
814
PUT
Invesco Solar ETF
TAN
$1.38B
| $23.3M | 0.01% |
261,200
+171,100
| +190% | +$13.9M |
|
815
W.P. Carey
WPC
$16.4B
| $23.3M | 0.01% |
319,169
-87,195
| -21% | -$6.38M |
|
|
DOCU
816
PUT
DocuSign
DOCU
$11.5B
| $23.2M | 0.01% |
83,000
+15,000
| +22% | +$3.35M |
|
817
CALL
Carnival Corporation Ltd
CCL
$39.7B
| $23.2M | 0.01% |
879,600
-640,200
| -42% | -$17.9M |
|
818
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
| $23.1M | 0.01% |
258,570
+229,860
| +801% | +$20M |
|
819
Vanguard Total Bond Market
BND
$161B
| $23.1M | 0.01% |
268,397
+1,824
| +0.7% | +$156K |
|
820
BorgWarner
BWA
$13.9B
| $23M | 0.01% |
539,281
+19,513
| +4% | +$859K |
|
821
Annaly Capital Management
NLY
$17.4B
| $23M | 0.01% |
647,253
-51,430
| -7% | -$1.87M |
|
822
Burlington
BURL
$23.2B
| $23M | 0.01% |
71,365
+21,996
| +45% | +$7M |
|
823
PUT
Lennar Class A
LEN
$21.2B
| $22.9M | 0.01% |
+238,416
| New | +$23M |
|
824
Textron
TXT
$15.4B
| $22.9M | 0.01% |
333,001
+67,161
| +25% | +$4.34M |
|
825
Advance Auto Parts
AAP
$3.49B
| $22.9M | 0.01% |
111,465
+22,157
| +25% | +$4.35M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.